BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8744610)

  • 1. Pulmonary vascular aspects of systemic sclerosis.
    Wallman LL; Penny R; Williamson DJ
    Aust N Z J Med; 1996 Apr; 26(2):150-3. PubMed ID: 8744610
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary arterial hypertension in systemic sclerosis: can we predict responders for successful therapy?
    Sasahara AA
    J Rheumatol; 2009 Apr; 36(4):665-6. PubMed ID: 19342719
    [No Abstract]   [Full Text] [Related]  

  • 3. Is exercise-induced pulmonary hypertension ready for prime time in systemic sclerosis?
    Steen VD; Champion H
    Int J Clin Pract Suppl; 2011 Jan; (169):1-3. PubMed ID: 21176008
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pulmonary hypertension, the "bĂȘte noire" of systemic diseases: from systemic sclerosis to hereditary hemorrhagic telangiectasia].
    Launay D
    Rev Med Interne; 2006 Nov; 27(11):899-902. PubMed ID: 17133666
    [No Abstract]   [Full Text] [Related]  

  • 5. Does the Left Heart Know What the Right Heart Is Doing in Patients With Systemic Sclerosis and Pulmonary Hypertension?
    Lammi MR; Agrawal V; Mathai SC
    Chest; 2024 Jun; 165(6):1288-1290. PubMed ID: 38852963
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening and therapy of pulmonary hypertension in systemic sclerosis.
    Bull TM
    Curr Opin Rheumatol; 2007 Nov; 19(6):598-603. PubMed ID: 17917541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension in systemic sclerosis: bete noire no more?
    Varga J
    Curr Opin Rheumatol; 2002 Nov; 14(6):666-70. PubMed ID: 12410089
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary arterial hypertension in systemic sclerosis: diagnostic pathway and therapeutic approach.
    Robertson L; Pignone A; Kowal-Bielecka O; Fiori G; Denton CP; Matucci-Cerinic M
    Ann Rheum Dis; 2005 Jun; 64(6):804-7. PubMed ID: 15897302
    [No Abstract]   [Full Text] [Related]  

  • 9. Right ventricular function in systemic sclerosis-associated pulmonary arterial hypertension.
    Koestenberger M; Ravekes W
    J Rheumatol; 2013 Jan; 40(1):90. PubMed ID: 23280165
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment and management of scleroderma lung disease.
    Bolster MB; Silver RM
    Curr Opin Rheumatol; 1999 Nov; 11(6):508-13. PubMed ID: 10551676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary arterial hypertension: are we doing enough to identify systemic sclerosis patients at high risk of this rare condition?
    Black C
    Rheumatology (Oxford); 2005 Feb; 44(2):141-2. PubMed ID: 15681336
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosing and managing scleroderma-related pulmonary arterial hypertension.
    Athanasiou KA; Sahni S; Rana A; Talwar A
    JAAPA; 2017 Sep; 30(9):11-18. PubMed ID: 28858011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular disease in systemic sclerosis.
    Poredos P
    Vasa; 2011 Jan; 40(1):3-4. PubMed ID: 21375075
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pulmonary arterial hypertension in collagen disease: experiences of the German Network for Systemic Scleroderma].
    Hunzelmann N; Riemekasten G
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S325-7. PubMed ID: 17139598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary Circulation on the Crossroads Between the Left and Right Heart in Systemic Sclerosis: A Clinical Challenge for Cardiologists and Rheumatologists.
    Gargani L; Voilliot D; D'Alto M; Agoston G; Moreo A; Serra W; Pieri F; Mori F; Wierzbowska-Drabik K; Matucci-Cerinic M; Moggi-Pignone A
    Heart Fail Clin; 2018 Jul; 14(3):271-281. PubMed ID: 29966626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IV epoprostenol for systemic sclerosis.
    Klings ES; Farber HW
    Chest; 2000 Sep; 118(3):881-2. PubMed ID: 10988225
    [No Abstract]   [Full Text] [Related]  

  • 17. Vascular reactivity and pulmonary hypertension in systemic sclerosis.
    Rozkovec A; Bernstein R; Asherson RA; Oakley CM
    Arthritis Rheum; 1983 Aug; 26(8):1037-40. PubMed ID: 6882479
    [No Abstract]   [Full Text] [Related]  

  • 18. Update in systemic sclerosis-associated pulmonary arterial hypertension.
    Gashouta MA; Humbert M; Hassoun PM
    Presse Med; 2014 Oct; 43(10 Pt 2):e293-304. PubMed ID: 25179278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring and Diagnostic Approaches for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis.
    Valenzuela A; Nandagopal S; Steen VD; Chung L
    Rheum Dis Clin North Am; 2015 Aug; 41(3):489-506. PubMed ID: 26210131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival in systemic sclerosis-related pulmonary arterial hypertension in the modern treatment era.
    Girgis RE; Mathai SC; Wigley FM; Hassoun PM
    Am J Respir Crit Care Med; 2009 Dec; 180(12):1280; author reply 1280-1. PubMed ID: 19949241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.